Aromatase regulation and breast cancer

Clin Endocrinol (Oxf). 2001 May;54(5):563-71. doi: 10.1046/j.1365-2265.2001.01276.x.
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Methoxyestradiol
  • Adult
  • Animals
  • Aromatase / analysis
  • Aromatase / metabolism*
  • Aromatase Inhibitors
  • Aryl Hydrocarbon Hydroxylases*
  • Breast / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / enzymology*
  • Cytochrome P-450 CYP2D6 / metabolism
  • Cytochrome P-450 Enzyme System / metabolism
  • Cytokines / metabolism
  • Dietary Fats / adverse effects
  • Dinoprostone / metabolism
  • Enzyme Activation
  • Enzyme Inhibitors / therapeutic use
  • Estradiol / analogs & derivatives
  • Estradiol / metabolism
  • Estrogens / metabolism*
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Letrozole
  • Middle Aged
  • Nitriles / therapeutic use
  • Obesity / enzymology
  • Pesticides / adverse effects
  • Steroid 16-alpha-Hydroxylase*
  • Steroid Hydroxylases / metabolism
  • Triazoles / therapeutic use

Substances

  • Aromatase Inhibitors
  • Cytokines
  • Dietary Fats
  • Enzyme Inhibitors
  • Estrogens
  • Nitriles
  • Pesticides
  • Triazoles
  • Estradiol
  • 2-Methoxyestradiol
  • Letrozole
  • Cytochrome P-450 Enzyme System
  • Steroid Hydroxylases
  • Aromatase
  • Aryl Hydrocarbon Hydroxylases
  • Cytochrome P-450 CYP2D6
  • Steroid 16-alpha-Hydroxylase
  • Dinoprostone